Established in 1929
Health City Sun
50¢
The
www.healthcitysun.com
September 16, 2022
New Mexico’s Legal & Financial Weekly
Vol. 10.102 No. 37
FORECLOSURE SALES: 0 PROBATE: 33 AUCTIONS: 6 NOTICE OF SUITS: 8 OTHER: 36 SPANISH NOTICES: 0
Medicinal Mushroom Supplement AHCC Helps Clear “Invisible” HPV Infections
*Publish Legal Notices for Less!*
68¢ / line for first week 52¢ / line for additional weeks
Sponsored copy courtesy of PrimeTimeNM.com
Y
ou may be among the 42 million Americans currently infected by the human papillomavirus (HPV) and not know it. HPV is the most common sexually transmitted infection in the United States, affecting more than 70 percent of sexually active adults at least once in their lifetimes. Unlike the “low-risk” HPV strains that produce visible lesions, “highrisk” HPV is an “invisible” infection that can lie undetected for decades and can lead to six different types of cancer; the two most common being cervical and head-and-neck cancers. A recent breakthrough in the study of HPV is providing physicians and patients with a new avenue for addressing high-risk infection. Researchers at the McGovern Medical School at UTHealth Houston studied the effect of a unique natural Japanese medicinal mushroom extract called AHCC® on women with persistent high-risk HPV infections. They found that daily use of AHCC® helped to clear an active HPV infection in two-thirds of study participants after only six months, while volunteers in the placebo group did not see comparable results.
“Our results showed that AHCC® supplementation helped the majority of patients in the AHCC® arm of the trial to become HPV-negative, The randomized double-blind placebo-controlled trial, considered to be therefore decreasing the long-term risk of HPV-related cancers,” says Dr. the gold standard protocol for clinical research, was co-funded by the Smith. “Importantly, through multiple studies, we have shown that AHCC National Institutes of Health (NIH) and published in the June 2022 issue of supplements are safe.” the prestigious medical journal Frontiers in Oncology. Current standard of care entails screening women for HPV during their regular gynecological exam. HPV usually goes undetected in men unless and until they are diagnosed with an HPV-associated cancer; as a result, they often spread the infection without knowing it. When a patient tests positive for HPV, the current protocol is often referred to as “watchful waiting” which entails monitoring the patient’s condition through regular exams but not providing any pharmacological or surgical treatment.
There are more than 30 human clinical studies and over 50 papers on AHCC® that have been published in Medline-indexed NIH-recognized scientific journals. AHCC® contains a unique combination of potent active components including alpha-glucans and axoglucan™ fractions, discovered by the Amino Up company of Sapporo, Japan. Numerous reputable supplement brands offer AHCC® in North America. Verified authentic products sold under the registered AHCC® trademark of Amino Up are listed on the AHCC Association website at www.AHCC.net.
This latest study shows that there is something that patients can do during this “waiting” period other than just passively anticipating their next exam. -(NewsUSA)